<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>Nuklearmedizin via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Nuklearmedizin' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Nuklearmedizin&t=Nuklearmedizin&s=Search&f=source]]></link>
        <lastBuildDate>Thu, 09 Feb 2012 03:37:48 +0100</lastBuildDate>
        <item>
            <title>Radioiodine remnant ablation in differentiated thyroid cancer after combined endogenous and exogenous TSH stimulation.</title>
            <link>http://www.medworm.com/index.php?rid=5666357&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22294096%26dopt%3DAbstract</link>
            <description>Conclusion: The third strategy of remnant ablation using a single injection of rhTSH after a brief THW period resulted in a significant higher rate of patients with residual uptake in the thyroid bed and a Tg level below 2 ng/ml three months after remnant ablation in comparison to THW. However, the overall efficacy of the third protocol was not significantly different as compared to two rhTSH injections. Under the aspect of the supply shortage of rhTSH the combined endogenous and exogenous TSH stimulation may be an attractive alternative for remnant ablation in differentiated thyroid cancer.
    PMID: 22294096 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5666357</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5666357</guid>        </item>
        <item>
            <title>[68Ga-labeled peptides for clinical trials - Production according to the German Drug Act: The Göttingen experience.]</title>
            <link>http://www.medworm.com/index.php?rid=5614736&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22249368%26dopt%3DAbstract</link>
            <description>Conclusions: The new German Drug Act is considered as a break in the production practice of nuclear medicine. The early involvement and communication with the authorities avoids time-consuming and costly planning errors. It is much to be hoped that the new legal situation in Germany will not cause serious impairments in the realization of clinical trials in German nuclear medicine.
    PMID: 22249368 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5614736</comments>
            <pubDate>Tue, 17 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5614736</guid>        </item>
        <item>
            <title>[Gastroenteropancreatic neuroendocrine tumors :  Diagnosis and therapy in nuclear medicine.]</title>
            <link>http://www.medworm.com/index.php?rid=5591053&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22231696%26dopt%3DAbstract</link>
            <description>[Gastroenteropancreatic neuroendocrine tumors : Diagnosis and therapy in nuclear medicine.]
    Internist (Berl). 2012 Jan 11;
    Authors: Haug AR, Bartenstein P
    Abstract
    The over expression of somatostatin receptors (SSTR) in neuroendocrine tumors (NET) enables diagnosis and targeted therapy using radio-labelled somatostatin analogues. PET with (68)Ga-DOTATATE or (68)Ga-DOTATOC, both with a high affinity to the SSTR subtype 2, enables diagnosis of NET with a very high sensitivity and has a significant influence on the therapeutic management of patients with NET. In particular, therapy with (177)Lu-DOTATATE, which offers a considerably lower nephrotoxicity as compared to (90)Y-DOTATOC, has only few side effects and is usually well tolerated. Up to 46% of patients suffering from GE...</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5591053</comments>
            <pubDate>Wed, 11 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5591053</guid>        </item>
        <item>
            <title>Apoptosis imaging to monitor cancer therapy: The road to fast treatment evaluation?</title>
            <link>http://www.medworm.com/index.php?rid=5572222&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22214506%26dopt%3DAbstract</link>
            <description>Authors: De Saint-Hubert M, Bauwens M, Verbruggen A, Mottaghy FM
    Abstract
    Molecular imaging of biological processes may allow detection of therapy effects before the tumor is reduced in size. The most frequently used PET tracer in oncology, 2-[18F]fluoro-2-deoxyglucose (FDG), suffers from low specificity due to uptake in inflammatory cells. The proliferation marker, 3'-[18F]fluoro-3'-deoxy-L-thymidine (FLT), is less influenced by the inflammatory response following therapy but here disease- and drug-specific effects need to be considered. Since cancer therapy mainly intends to eliminate cancer cells, imaging of cell death offers a direct way to image therapy response. This review gives an overview of the radiopharmaceutical development and in vivo evaluation of radioligands that ha...</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5572222</comments>
            <pubDate>Mon, 02 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5572222</guid>        </item>
        <item>
            <title>Fluoreszenz-Markierung mittels Indocyanin-Grün bei der Sentinel-Lymphknoten-Exstirpation in der Dermatoonkologie.</title>
            <link>http://www.medworm.com/index.php?rid=5572223&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22212145%26dopt%3DAbstract</link>
            <description>Authors: Stoffels I, von der Stück H, Boy C, Pöppel T, Körber N, Weindorf M, Dissemond J, Schadendorf D, Klode J
    PMID: 22212145 [PubMed - in process] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5572223</comments>
            <pubDate>Sun, 01 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5572223</guid>        </item>
        <item>
            <title>[Magnetic Particle Imaging (MPI).]</title>
            <link>http://www.medworm.com/index.php?rid=5556987&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22198836%26dopt%3DAbstract</link>
            <description>Authors: Haegele J, Sattel T, Erbe M, Luedtke-Buzug K, Taupitz M, Borgert J, Buzug TM, Barkhausen J, Vogt FM
    Abstract
    Magnetic particle imaging (MPI) displays the spatial distribution and concentration of superparamagnetic iron oxides (SPIOs). It is a quantitative, tomographic imaging method with high temporal and spatial resolution and allows work with high sensitivity yet without ionizing radiation. Thus, it may be a very promising tool for medical imaging. In this review, we describe the physical and technical basics and various concepts for clinical scanners. Furthermore, clinical applications such as cardiovascular imaging, interventional procedures, imaging and therapy of malignancies as well as molecular imaging are presented.
    PMID: 22198836 [PubMed - as supplied by publ...</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5556987</comments>
            <pubDate>Fri, 23 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5556987</guid>        </item>
        <item>
            <title>Bone erosion due to aortic prosthesis by 18F-FDG-PET/CT.</title>
            <link>http://www.medworm.com/index.php?rid=5522161&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22138705%26dopt%3DAbstract</link>
            <description>Authors: Sabet A, Strunk H, Ahmadzadehfar H, Welz A, Biersack HJ, Ezziddin S
    PMID: 22138705 [PubMed - in process] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5522161</comments>
            <pubDate>Wed, 21 Dec 2011 02:54:02 +0100</pubDate>
            <guid isPermaLink="false">5522161</guid>        </item>
        <item>
            <title>Unexpected only pulmonary manifestation of sarcoidosis.</title>
            <link>http://www.medworm.com/index.php?rid=5522160&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22138706%26dopt%3DAbstract</link>
            <description>Authors: Bodmann B, Havranek V, Kneussl M, Czernin J, Knoll P, Mirzaei S
    PMID: 22138706 [PubMed - in process] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5522160</comments>
            <pubDate>Wed, 21 Dec 2011 02:54:02 +0100</pubDate>
            <guid isPermaLink="false">5522160</guid>        </item>
        <item>
            <title>18F-FDG-PET/CT in myelofibrosis.</title>
            <link>http://www.medworm.com/index.php?rid=5522159&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22138707%26dopt%3DAbstract</link>
            <description>Authors: Behrendt FF, Krohn T, Palmowski M, Mottaghy FM
    PMID: 22138707 [PubMed - in process] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5522159</comments>
            <pubDate>Wed, 21 Dec 2011 02:54:02 +0100</pubDate>
            <guid isPermaLink="false">5522159</guid>        </item>
        <item>
            <title>Cost comparison of (111)In-DTPA-octreotide scintigraphy and (68)Ga-DOTATOC PET/CT in Germany: two sides of two different coins.</title>
            <link>http://www.medworm.com/index.php?rid=5522157&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22160153%26dopt%3DAbstract</link>
            <description>Authors: Ruf J
    PMID: 22160153 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5522157</comments>
            <pubDate>Sat, 10 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5522157</guid>        </item>
        <item>
            <title>[Assessment of Patient Movement in Interventional Procedures Using Electromagnetic Detection - Comparison Between Conventional Fixation and Vacuum Mattress.]</title>
            <link>http://www.medworm.com/index.php?rid=5522156&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22161235%26dopt%3DAbstract</link>
            <description>CONCLUSION: Patient positioning on a vacuum mattress is fast, easy, comfortable for the patient and reduces relevant patient movements. Therefore, vacuum mattress positioning can be used for image-guided interventions relying on preprocedural imaging data, where minimal patient movement is a prerequisite.
    PMID: 22161235 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5522156</comments>
            <pubDate>Fri, 09 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5522156</guid>        </item>
        <item>
            <title>[Whole-body MRI in preoperative diagnostics of breast cancer - a comparison with staging methods according to the s 3 guidelines].</title>
            <link>http://www.medworm.com/index.php?rid=5522158&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22144067%26dopt%3DAbstract</link>
            <description>Authors: Hausmann D, Kern C, Schröder MT, Sütterlin M, Schönberg SO, Neff KW, Dinter DJ
    PMID: 22144067 [PubMed - in process] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5522158</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5522158</guid>        </item>
        <item>
            <title>[German Academy for Microtherapy (&quot;DAfMT&quot;) - Modern, Image-Guided, Minimally Invasive, Microtherapeutic, Partially Interdisciplinary Approaches to Treatment for Clinical Education and Practice].</title>
            <link>http://www.medworm.com/index.php?rid=5522155&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22167459%26dopt%3DAbstract</link>
            <description>[German Academy for Microtherapy (&quot;DAfMT&quot;) - Modern, Image-Guided, Minimally Invasive, Microtherapeutic, Partially Interdisciplinary Approaches to Treatment for Clinical Education and Practice].
    Zentralbl Chir. 2011 Dec;136(6):634-5
    Authors: Dudeck O, Weigt J, Schubert D, Meyer F, Malfertheiner P, Lippert H, Ricke J
    PMID: 22167459 [PubMed - in process] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5522155</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5522155</guid>        </item>
        <item>
            <title>[Traumatic brain injury in the age of the magic potion.]</title>
            <link>http://www.medworm.com/index.php?rid=5449323&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22113520%26dopt%3DAbstract</link>
            <description>Authors: Ahlhelm FJ
    PMID: 22113520 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5449323</comments>
            <pubDate>Fri, 25 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5449323</guid>        </item>
        <item>
            <title>Standardisation and harmonisation boost the credibility of nuclear medicine procedures.</title>
            <link>http://www.medworm.com/index.php?rid=5431101&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22089662%26dopt%3DAbstract</link>
            <description>Authors: Tatsch K
    PMID: 22089662 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5431101</comments>
            <pubDate>Thu, 17 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5431101</guid>        </item>
        <item>
            <title>Performance Measurements of the Siemens mMR Integrated Whole-Body PET/MR Scanner.</title>
            <link>http://www.medworm.com/index.php?rid=5431102&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22080447%26dopt%3DAbstract</link>
            <description>CONCLUSION: These results compare favorably with other state-of-the-art PET/CT and PET/MR scanners, indicating that the integration of the PET detectors in the MR scanner and their operation within the magnetic field do not have a perceptible impact on the overall performance. The MR subsystem performs essentially like a standalone system. However, further work is necessary to evaluate the more advanced MR applications, such as functional imaging and spectroscopy.
    PMID: 22080447 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5431102</comments>
            <pubDate>Mon, 14 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5431102</guid>        </item>
        <item>
            <title>[Whole-Body MRI in Preoperative Diagnostics of Breast Cancer - a Comparison of Staging Methods According to the S 3 Guidelines.]</title>
            <link>http://www.medworm.com/index.php?rid=5431103&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22068844%26dopt%3DAbstract</link>
            <description>CONCLUSION: The detection of distant metastases has an important impact on patient management. In this study WB-MRI in breast cancer staging has shown promising results in regard to possible clinical implementation as a matter of routine staging.
    PMID: 22068844 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5431103</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5431103</guid>        </item>
        <item>
            <title>[In process citation].</title>
            <link>http://www.medworm.com/index.php?rid=5365465&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22043494%26dopt%3DAbstract</link>
            <description>Authors: Luster M, Simon D
    PMID: 22043494 [PubMed - in process] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5365465</comments>
            <pubDate>Thu, 03 Nov 2011 23:15:15 +0100</pubDate>
            <guid isPermaLink="false">5365465</guid>        </item>
        <item>
            <title>Zum benefit der patienten: die schildwächterlymphknotenentfernung.</title>
            <link>http://www.medworm.com/index.php?rid=5365468&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22026360%26dopt%3DAbstract</link>
            <description>Authors: Satzger I, Klein M, Löser C, Möhrle M, Reske S, Kapp A, Gutzmer R
    PMID: 22026360 [PubMed - in process] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5365468</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5365468</guid>        </item>
        <item>
            <title>Automatic volume delineation in oncological PET. Evaluation of a dedicated software tool and comparison with manual delineation in clinical data sets.</title>
            <link>http://www.medworm.com/index.php?rid=5365467&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22027997%26dopt%3DAbstract</link>
            <description>Conclusion: The evaluated software provides results in very good agreement with observer-averaged manual evaluations, facilitates and accelerates the volumetric evaluation, eliminates the problem of interobserver variability and appears to be a useful tool for volumetric evaluation of oncological PET in clinical routine.
    PMID: 22027997 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5365467</comments>
            <pubDate>Wed, 26 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5365467</guid>        </item>
        <item>
            <title>Hepatic Toxicity After Radioembolization of the Liver Using (90)Y-Microspheres: Sequential Lobar Versus Whole Liver Approach.</title>
            <link>http://www.medworm.com/index.php?rid=5365466&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22037709%26dopt%3DAbstract</link>
            <description>CONCLUSIONS:            Noncirrhotic patients undergoing sequential lobar radioembolization had less hepatic toxicity compared to whole liver embolization. The sequential approach should be the preferred strategy.
    PMID: 22037709 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5365466</comments>
            <pubDate>Wed, 26 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5365466</guid>        </item>
        <item>
            <title>68Ga-NODAGA-RGDyK for αvβ3 integrin PET imaging. Preclinical investigation and dosimetry.</title>
            <link>http://www.medworm.com/index.php?rid=5365470&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21989840%26dopt%3DAbstract</link>
            <description>Conclusion: NODAGA-RGDyK was reliably labeled with 68Ga and revealed a predicted ED of 0.014 mSv/MBq. Tumour uptake was rapid and significant and was chased with unlabeled RGDyK in a similar manner as adrenal uptake.
    PMID: 21989840 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5365470</comments>
            <pubDate>Tue, 11 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5365470</guid>        </item>
        <item>
            <title>Cryptate mediated nucleophilic 18F-fluorination without azeotropic drying.</title>
            <link>http://www.medworm.com/index.php?rid=5365469&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21989864%26dopt%3DAbstract</link>
            <description>Conclusion: SAX-resin adsorbed [18F]fluoride can be dried with non-aqueous solvents and eluted with [K+⊂2.2.2]OH- in CH3CN. The reactivity of [K+⊂2.2.2]F- generated by the new method is comparable to that of [18F]fluoride obtained by azeotropic drying. The described procedure facilitates the automated production of 18F-radiopharmaceuticals in general, and may also simplify the use of microfluidic devices for 18F-radiotracer production.
    PMID: 21989864 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5365469</comments>
            <pubDate>Tue, 11 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5365469</guid>        </item>
        <item>
            <title>[Optimization of the fine needle aspiration biopsy (FNAB) of thyroid nodules- automatic aspirator versus manual technique].</title>
            <link>http://www.medworm.com/index.php?rid=5270400&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21727989%26dopt%3DAbstract</link>
            <description>Conclusion: The automatic microaspirator is superior to the manual aspiration. Moreover, under sonographic control it is more convenient, to biopsy even very small nodules and lesiosn (down to 4 mm in diameter).
    PMID: 21727989 [PubMed - in process] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5270400</comments>
            <pubDate>Sat, 01 Oct 2011 19:35:02 +0100</pubDate>
            <guid isPermaLink="false">5270400</guid>        </item>
        <item>
            <title>211At-AntiCD33 in NMRI nu/nu mice. Biodistribution, in vivo stability and radiotoxicity.</title>
            <link>http://www.medworm.com/index.php?rid=5270399&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21789339%26dopt%3DAbstract</link>
            <description>Conclusion: The radiolabelling method yielded adequate in vivo stability of 211At-antiCD33. Biodistribution with rapid elimination of free 211At via kidneys and urine complies with requirements for targeted therapy. Activity doses potentially required for treatment do not elicit radiotoxicity to normal organs in mice. Further development is required to enhance the apparent specific activity and to verify the efficacy in an adequate animal model before phase I clinical studies in leukaemia can be envisaged.
    PMID: 21789339 [PubMed - in process] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5270399</comments>
            <pubDate>Sat, 01 Oct 2011 19:35:02 +0100</pubDate>
            <guid isPermaLink="false">5270399</guid>        </item>
        <item>
            <title>[Scintigraphically &quot;hot&quot; thyroid nodules mainly go hand in hand with a normal TSH].</title>
            <link>http://www.medworm.com/index.php?rid=5270398&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21789340%26dopt%3DAbstract</link>
            <description>Conclusions: In Germany, in at far the largest proportion of patients with autonomous thyroid nodules objectified by means of scintigraphy, TSH levels are within the normal range. Since such nodules with maximum safety can be classified as benign, a corresponding scintigraphic finding has a high priority for the patient. These current data support that it is not reasonable to restrict scintigraphy to patients with subnormal TSH values in this country.
    PMID: 21789340 [PubMed - in process] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5270398</comments>
            <pubDate>Sat, 01 Oct 2011 19:35:02 +0100</pubDate>
            <guid isPermaLink="false">5270398</guid>        </item>
        <item>
            <title>Suspected osseous recurrence visualized on a 68Ga-DOTATATE PET/CT scan during the follow-up of a patient with a resected pulmonary carcinoid tumour.</title>
            <link>http://www.medworm.com/index.php?rid=5270395&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21953072%26dopt%3DAbstract</link>
            <description>Authors: Geiger S, Horster S, Haug AR, Hausmann A, Schlemmer M, Stemmler HJ
    PMID: 21953072 [PubMed - in process] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5270395</comments>
            <pubDate>Sat, 01 Oct 2011 19:35:02 +0100</pubDate>
            <guid isPermaLink="false">5270395</guid>        </item>
        <item>
            <title>Computed tomography-guided brachytherapy for liver cancer.</title>
            <link>http://www.medworm.com/index.php?rid=5270401&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21939858%26dopt%3DAbstract</link>
            <description>Authors: Ricke J, Wust P
    Abstract
    Limitations of thermal liver cancer ablation have led to the development of percutaneous, catheter-based brachytherapy for the treatment of liver malignancies. Computed tomography (CT)-guided brachytherapy has been used to treat primary and metastatic liver cancers, including very large tumors &amp;gt;10 cm. Cooling effects by adjacent blood vessels are not a concern in brachytherapy, and the method may be used safely in tumors unsuitable for thermal ablation that are close to the liver hilum due to the relatively high radiation tolerance of bile duct. CT scanning is used for dosimetry planning after catheter implantation and also to guide the catheter placement itself. Major complications, including postinterventional bleeding, are rare despite freque...</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5270401</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5270401</guid>        </item>
        <item>
            <title>[Imaging for intensive care medicine and emergency medicine.]</title>
            <link>http://www.medworm.com/index.php?rid=5270396&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21952929%26dopt%3DAbstract</link>
            <description>Authors: Heußel CP
    PMID: 21952929 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5270396</comments>
            <pubDate>Thu, 29 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5270396</guid>        </item>
        <item>
            <title>Efficacy of diphenhydramine in the prevention of vertigo and nausea at 7T MRI.</title>
            <link>http://www.medworm.com/index.php?rid=5270397&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21945402%26dopt%3DAbstract</link>
            <description>CONCLUSION: Diphenhydramine, even at a low dose, reduces the strength of vertigo at ultra-high static magnetic fields, may be used preventively, and could pave the way to even higher field strength.
    PMID: 21945402 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5270397</comments>
            <pubDate>Sat, 24 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5270397</guid>        </item>
        <item>
            <title>[In Process Citation].</title>
            <link>http://www.medworm.com/index.php?rid=5237374&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21919284%26dopt%3DAbstract</link>
            <description>Authors: Freudenberg LS
    PMID: 21919284 [PubMed - in process] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5237374</comments>
            <pubDate>Wed, 21 Sep 2011 20:12:01 +0100</pubDate>
            <guid isPermaLink="false">5237374</guid>        </item>
        <item>
            <title>Biological dosimetry after radiosynoviorthesis with rhenium-186 sulphide and erbium-169 citrate.</title>
            <link>http://www.medworm.com/index.php?rid=5237373&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21931934%26dopt%3DAbstract</link>
            <description>Conclusions: No significant biological radiation effect can be detected after RSO with 186Re and 169Er, also in cases of high leakage. Therefore, RSO can be classified as a save therapeutic procedure without a relevant radiation risk.
    PMID: 21931934 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5237373</comments>
            <pubDate>Tue, 20 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5237373</guid>        </item>
        <item>
            <title>Lymphocyte function following radioiodine therapy in patients with thyroid carcinoma.</title>
            <link>http://www.medworm.com/index.php?rid=5209674&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21887454%26dopt%3DAbstract</link>
            <description>Conclusion: Thyroid carcinoma patients receiving radioiodine therapy do not display any sign of immunosuppression.
    PMID: 21887454 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5209674</comments>
            <pubDate>Fri, 02 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5209674</guid>        </item>
        <item>
            <title>[Interventional radiology - state of the art].</title>
            <link>http://www.medworm.com/index.php?rid=5182753&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21882128%26dopt%3DAbstract</link>
            <description>Authors: Helmberger T
    PMID: 21882128 [PubMed - in process] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5182753</comments>
            <pubDate>Wed, 31 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5182753</guid>        </item>
        <item>
            <title>Hard beta and gamma emissions of 124I. Impact on occupational dose in PET/CT.</title>
            <link>http://www.medworm.com/index.php?rid=5182754&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21876870%26dopt%3DAbstract</link>
            <description>Conclusion: The highly energetic positrons emitted by 124I can cause high skin doses if radioprotection is poor. Under optimized conditions occupational doses are acceptable. Education of workers is of paramount importance.
    PMID: 21876870 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5182754</comments>
            <pubDate>Mon, 29 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5182754</guid>        </item>
        <item>
            <title>Brain metastasis in lung cancer. Comparison of cerebral MRI and 18F-FDG-PET/CT for diagnosis in the initial staging.</title>
            <link>http://www.medworm.com/index.php?rid=5169905&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21165538%26dopt%3DAbstract</link>
            <description>CONCLUSION: In patients with a curative option MRI should be performed additionally to PET/CT for definitive exclusion of brain metastases.
    PMID: 21165538 [PubMed - indexed for MEDLINE] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5169905</comments>
            <pubDate>Sun, 28 Aug 2011 18:00:03 +0100</pubDate>
            <guid isPermaLink="false">5169905</guid>        </item>
        <item>
            <title>(131)I therapy in patients with benign thyroid disease does not conclusively lead to a higher risk of subsequent malignancies.</title>
            <link>http://www.medworm.com/index.php?rid=5169904&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21165539%26dopt%3DAbstract</link>
            <description>CONCLUSION: As over 60 years of experience has thus far failed to produce conclusive evidence to the contrary, it can be concluded that there is no increased risk of malignancies after 131I therapy for benign thyroid disease.
    PMID: 21165539 [PubMed - indexed for MEDLINE] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5169904</comments>
            <pubDate>Sun, 28 Aug 2011 18:00:03 +0100</pubDate>
            <guid isPermaLink="false">5169904</guid>        </item>
        <item>
            <title>Can (18)F-FDG PET/CT predict recurrence in patients with cutaneous malignant melanoma?</title>
            <link>http://www.medworm.com/index.php?rid=5169903&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21246162%26dopt%3DAbstract</link>
            <description>CONCLUSION: Preoperative SUVmax of primary lesion was found to be the most potent predictor of recurrence in CMM patient. Patients with high SUV max of primary lesion should be followed meticulously for recurrence.
    PMID: 21246162 [PubMed - indexed for MEDLINE] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5169903</comments>
            <pubDate>Sun, 28 Aug 2011 18:00:03 +0100</pubDate>
            <guid isPermaLink="false">5169903</guid>        </item>
        <item>
            <title>Sentinel node mapping in the prostate cancer. Meta-analysis.</title>
            <link>http://www.medworm.com/index.php?rid=5169902&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21264441%26dopt%3DAbstract</link>
            <description>CONCLUSION: SL biopsy can prevent unnecessary pelvic lymph node dissection in prostate cancer patients. This procedure is feasible with low false negative rate and high detection rate.
    PMID: 21264441 [PubMed - indexed for MEDLINE] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5169902</comments>
            <pubDate>Sun, 28 Aug 2011 18:00:03 +0100</pubDate>
            <guid isPermaLink="false">5169902</guid>        </item>
        <item>
            <title>(99m)Tc-prulifloxacin in artificially infected animals. Radiosynthesis and biological evaluation.</title>
            <link>http://www.medworm.com/index.php?rid=5169901&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21340097%26dopt%3DAbstract</link>
            <description>CONCLUSION: This investigation of 99mTc-PRN confirmed its momentous radiochemical immovability in saline, serum, preferential in-vitro binding to living bacteria, higher uptake in the infected muscle of model RT and precise localization in the infected muscle of model RB.
    PMID: 21340097 [PubMed - indexed for MEDLINE] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5169901</comments>
            <pubDate>Sun, 28 Aug 2011 18:00:03 +0100</pubDate>
            <guid isPermaLink="false">5169901</guid>        </item>
        <item>
            <title>A comparison between GATE4 results and MCNP4B published data for internal radiation dosimetry.</title>
            <link>http://www.medworm.com/index.php?rid=5169900&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21340098%26dopt%3DAbstract</link>
            <description>CONCLUSION: Despite of differences between the GATE4 and MCNP4B, the results can be considered ensuring. This may be considered as validation of GATE/GEANT as a proprietary code in nuclear medicine for radionuclide dosimetry applications.
    PMID: 21340098 [PubMed - indexed for MEDLINE] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5169900</comments>
            <pubDate>Sun, 28 Aug 2011 18:00:03 +0100</pubDate>
            <guid isPermaLink="false">5169900</guid>        </item>
        <item>
            <title>Quantitative in vivo assessment of radiation injury of the liver using Gd-EOB-DTPA enhanced MRI: tolerance dose of small liver volumes.</title>
            <link>http://www.medworm.com/index.php?rid=5169899&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21496320%26dopt%3DAbstract</link>
            <description>CONCLUSION: Hepatic injury peaked 6 weeks after small volume irradiation. Ongoing repair was observed up to 6 months. Individual dose sensitivity may differ as demonstrated by a relatively high standard deviation of threshold values in our own as well as all other published data.
    PMID: 21496320 [PubMed - indexed for MEDLINE] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5169899</comments>
            <pubDate>Sun, 28 Aug 2011 18:00:03 +0100</pubDate>
            <guid isPermaLink="false">5169899</guid>        </item>
        <item>
            <title>A severe haematologic adverse reaction after high dosage radioiodine therapy following blood stem cell mobilization with growth factors.</title>
            <link>http://www.medworm.com/index.php?rid=5127295&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21833439%26dopt%3DAbstract</link>
            <description>Authors: Freesmeyer M
    
    PMID: 21833439 [PubMed - in process] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5127295</comments>
            <pubDate>Mon, 15 Aug 2011 07:15:04 +0100</pubDate>
            <guid isPermaLink="false">5127295</guid>        </item>
        <item>
            <title>Investigation for extrahepatic shunt before SIRT by PET/CT with 68Ga-MAA.</title>
            <link>http://www.medworm.com/index.php?rid=5127294&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21833440%26dopt%3DAbstract</link>
            <description>Authors: Gartenschlaeger M, Maus S, Buchholz H, Reber H, Pitton N, Schreckenberger M
    
    PMID: 21833440 [PubMed - in process] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5127294</comments>
            <pubDate>Mon, 15 Aug 2011 07:15:04 +0100</pubDate>
            <guid isPermaLink="false">5127294</guid>        </item>
        <item>
            <title>Post-radiosynovectomy 90Y-PET imaging.</title>
            <link>http://www.medworm.com/index.php?rid=5127293&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21833441%26dopt%3DAbstract</link>
            <description>Authors: Prechtel HW, Verburg FA, Dautzenberg KJ, Mottaghy FM, Behrendt FF, Krohn T
    
    PMID: 21833441 [PubMed - in process] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5127293</comments>
            <pubDate>Mon, 15 Aug 2011 07:15:04 +0100</pubDate>
            <guid isPermaLink="false">5127293</guid>        </item>
        <item>
            <title>Leaving relativity behind quantitative clinical perfusion imaging.</title>
            <link>http://www.medworm.com/index.php?rid=5127296&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21816312%26dopt%3DAbstract</link>
            <description>Authors: Bengel FM
    
    PMID: 21816312 [PubMed - in process] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5127296</comments>
            <pubDate>Mon, 08 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5127296</guid>        </item>
        <item>
            <title>Rhenium-188 labeled recombinant human plasminogen kringle5 (rhk5) and preliminary biodistribution. Evaluation in mice bearing A549 tumours.</title>
            <link>http://www.medworm.com/index.php?rid=5127298&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21808809%26dopt%3DAbstract</link>
            <description>Conclusion: 188Re-rhk5 was prepared by a simple method. Preliminary biodistribution results showed its potential as an agent for possible tumour imaging, therapy and encouraged further investigation.
    PMID: 21808809 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5127298</comments>
            <pubDate>Mon, 01 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5127298</guid>        </item>
        <item>
            <title>New Molecular Markers for Prostate Tumor Imaging: A Study on 2-Methylene Substituted Fatty Acids as New AMACR Inhibitors.</title>
            <link>http://www.medworm.com/index.php?rid=5127297&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21812041%26dopt%3DAbstract</link>
            <description>Authors: Morgenroth A, Urusova EA, Dinger C, Al-Momani E, Kull T, Glatting G, Frauendorf H, Jahn O, Mottaghy FM, Reske SN, Zlatopolskiy BD
    The development of prostate carcinoma is associated with alterations in fatty acid metabolism. α-Methylacyl-CoA racemase (AMACR) is a peroxisomal and mitochondrial enzyme that catalyses interconversion between the (S)/(R)-isomers of a range of α-methylacyl-CoA thioesters. AMACR is involved in the β-oxidation of the dietary branched-chain fatty acids and bile acid intermediates. It is highly expressed in prostate (more than 95 %), colon (92 %), and breast cancers (44 %) but not in the respective normal or hyperplastic tissues. Thus, targeting of AMACR could be a new strategy for molecular imaging and therapy of prostate and some other cancer...</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5127297</comments>
            <pubDate>Mon, 01 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5127297</guid>        </item>
        <item>
            <title>Matched-Pair Comparison of Radioembolization Plus Best Supportive Care Versus Best Supportive Care Alone for Chemotherapy Refractory Liver-Dominant Colorectal Metastases.</title>
            <link>http://www.medworm.com/index.php?rid=5079098&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21800231%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Radioembolization offers a promising addition to BSC in treatment-refractory patients for whom there are limited options. Survival was prolonged and adverse events were generally mild-to-moderate in nature and manageable.
    PMID: 21800231 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5079098</comments>
            <pubDate>Thu, 28 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5079098</guid>        </item>
        <item>
            <title>[Scintigraphically &quot;hot&quot; thyroid nodules mainly go hand in hand with a normal TSH.]</title>
            <link>http://www.medworm.com/index.php?rid=5079113&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21789340%26dopt%3DAbstract</link>
            <description>Conclusions: In Germany, in at far the largest proportion of patients with autonomous thyroid nodules objectified by means of scintigraphy, TSH levels are within the normal range. Since such nodules with maximum safety can be classified as benign, a corresponding scintigraphic finding has a high priority for the patient. These current data support that it is not reasonable to restrict scintigraphy to patients with subnormal TSH values in this country.
    PMID: 21789340 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5079113</comments>
            <pubDate>Thu, 07 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5079113</guid>        </item>
        <item>
            <title>[Optimization of the fine needle aspiration biopsy (FNAB) of thyroid nodules- automatic aspirator versus manual technique.]</title>
            <link>http://www.medworm.com/index.php?rid=5032671&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21727989%26dopt%3DAbstract</link>
            <description>Conclusion: The automatic microaspirator is superior to the manual aspiration. Moreover, under sonographic control it is more convenient, to biopsy even very small nodules and lesiosn (down to 4 mm in diameter).
    PMID: 21727989 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5032671</comments>
            <pubDate>Mon, 04 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5032671</guid>        </item>
        <item>
            <title>Preoperative risk stratification using 18F-FDG PET/CT in women with endometrial cancer.</title>
            <link>http://www.medworm.com/index.php?rid=5032670&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21727990%26dopt%3DAbstract</link>
            <description>Conclusion: High-risk endometrial cancer might be differentiated by means of higher SUVmax from low-risk endometrial cancer. 18F-FDG FDG PET/CT can be applied preoperatively for stratification of risk in patients with endometrial cancer.
    PMID: 21727990 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5032670</comments>
            <pubDate>Mon, 04 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5032670</guid>        </item>
        <item>
            <title>FDG PET/CT in cancer therapy monitoring: computer-assisted analysis of baseline together with up to two follow-ups.</title>
            <link>http://www.medworm.com/index.php?rid=4935224&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21165536%26dopt%3DAbstract</link>
            <description>Authors: Apostolova I, Renisch S, Opfer R, Derlin T, Buchert R, Carlsen IC, Brenner W
    We developed and tested a software tool for computer-assisted analysis of FDG-PET/CT in cancer therapy monitoring. The tool provides automatic semi-quantitative analysis of a baseline scan together with up to two follow-up scans (standardized uptake values, glycolytic volume). The tool also supports visual analysis by local spatial registration which allows display of tumor lesions with the same orientation in all scans. The tool's stability and accuracy was tested at typical everyday image quality.
    PMID: 21165536 [PubMed - indexed for MEDLINE] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4935224</comments>
            <pubDate>Fri, 17 Jun 2011 15:30:03 +0100</pubDate>
            <guid isPermaLink="false">4935224</guid>        </item>
        <item>
            <title>[Diagnostic reference value. Critical evaluation of the term with the example of nuclear medicine studies in Austria].</title>
            <link>http://www.medworm.com/index.php?rid=4935223&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21340096%26dopt%3DAbstract</link>
            <description>CONCLUSION: The published diagnostic reference values correspond to the normal investigative practice in Austria and are compliant with most international recommendations. The term &quot;optimal value&quot; has been removed from the text of the law, because such wording would be misleading.
    PMID: 21340096 [PubMed - indexed for MEDLINE] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4935223</comments>
            <pubDate>Fri, 17 Jun 2011 15:30:03 +0100</pubDate>
            <guid isPermaLink="false">4935223</guid>        </item>
        <item>
            <title>[The Tower of Babel].</title>
            <link>http://www.medworm.com/index.php?rid=4935222&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21542196%26dopt%3DAbstract</link>
            <description>Authors: Burchert W
    
    PMID: 21542196 [PubMed - indexed for MEDLINE] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4935222</comments>
            <pubDate>Fri, 17 Jun 2011 15:30:03 +0100</pubDate>
            <guid isPermaLink="false">4935222</guid>        </item>
        <item>
            <title>PET in testicular cancer.</title>
            <link>http://www.medworm.com/index.php?rid=4890811&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21331937%26dopt%3DAbstract</link>
            <description>Authors: Becherer A
    Testicular cancer is a rare tumor, subdivided into seminomatous and nonseminomatous tumors. Whereas there are no serum tumor markers in the first group, they are present in nonseminomatous tumors, and are also important prognostic factors. Overall, the prognosis for testicular cancers is good, which makes the choice of accurate treatment intensity between under- and overtreatment often difficult. Residual masses in advanced clinical stages occur frequently but are nonvital tissue. PET with F-18 FDG has no defined role in imaging of primary tumors where CT is the first-choice imaging modality. For assessing the success of chemotherapy in the presence of residual masses, especially in pure seminoma, F-18 FDG PET is an important tool. In nonseminomatous tumors, it is h...</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4890811</comments>
            <pubDate>Fri, 03 Jun 2011 08:00:08 +0100</pubDate>
            <guid isPermaLink="false">4890811</guid>        </item>
        <item>
            <title>Follow-up of FDG-PET/CT findings in retroperitoneal fibrosis associated with abdominal aortic aneurysm.</title>
            <link>http://www.medworm.com/index.php?rid=4890808&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21611677%26dopt%3DAbstract</link>
            <description>Authors: Wiggermann P, Aust D, Stroszczynski C, Kotzerke J, Zöphel K
    
    PMID: 21611677 [PubMed - in process] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4890808</comments>
            <pubDate>Fri, 03 Jun 2011 08:00:08 +0100</pubDate>
            <guid isPermaLink="false">4890808</guid>        </item>
        <item>
            <title>Anatomical accuracy of abdominal lesion localization. Retrospective automatic rigid image registration between FDG-PET and MRI.</title>
            <link>http://www.medworm.com/index.php?rid=4890810&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21594303%26dopt%3DAbstract</link>
            <description>Conclusion: The misalignment between FDG-PET and abdominal MRI registered using an automated rigid registration tool was comparable to data reported for software-based fusion between PET and CT. Although this imprecision may not affect diagnostic accuracy, it is not sufficient to allow for pixel-wise integration of MRI and PET information.
    PMID: 21594303 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4890810</comments>
            <pubDate>Wed, 18 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4890810</guid>        </item>
        <item>
            <title>Metabolic tumour volume. Prognostic value in locally advanced squamous cell carcinoma of the head and neck.</title>
            <link>http://www.medworm.com/index.php?rid=4890809&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21594304%26dopt%3DAbstract</link>
            <description>Conclusion: Summed MTV50 values of both the primary tumour and involved lymph nodes provided independent prognostic information on disease free and overall survival.
    PMID: 21594304 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4890809</comments>
            <pubDate>Wed, 18 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4890809</guid>        </item>
        <item>
            <title>(86)Y-DOTATOC uptake in red marrow is not routinely visible.</title>
            <link>http://www.medworm.com/index.php?rid=4842154&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21567251%26dopt%3DAbstract</link>
            <description>Authors: Hartmann H, Oehme L, Kotzerke J
    
    PMID: 21567251 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4842154</comments>
            <pubDate>Thu, 12 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4842154</guid>        </item>
        <item>
            <title>Comparison of dopamine turnover, dopamine influx constant and activity ratio of striatum and occipital brain with (18)F-dopa brain PET in normal controls and patients with Parkinson's disease.</title>
            <link>http://www.medworm.com/index.php?rid=4842155&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21553090%26dopt%3DAbstract</link>
            <description>CONCLUSION: For clinical applications, our data do not demonstrate any superiority of the EDVR determination compared to influx rate constant, while requiring long and tedious acquisition protocols. The normal range estimates do not represent absolute quantitative measures for dopamine metabolism but are specific for the chosen acquisition and processing procedures.
    PMID: 21553090 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4842155</comments>
            <pubDate>Fri, 06 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4842155</guid>        </item>
        <item>
            <title>Retrospective web-based multicenter evaluation of ¹⁸F-FDG-PET and CT derived predictive factors. Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan in follicular non Hodgkin's lymphoma.</title>
            <link>http://www.medworm.com/index.php?rid=4783604&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21057722%26dopt%3DAbstract</link>
            <description>Conclusion: The use of a web-based multicenter archiving system for clinical and imaging data is technically feasible in a multicenter setting and allows a central analysis. This preliminary analysis suggests that FDG-PET may predict the likelihood of response to RIT.
    PMID: 21057722 [PubMed - indexed for MEDLINE] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4783604</comments>
            <pubDate>Thu, 05 May 2011 17:30:06 +0100</pubDate>
            <guid isPermaLink="false">4783604</guid>        </item>
        <item>
            <title>Two or four hour [¹⁸F]FMISO-PET in HNSCC. When is the contrast best?</title>
            <link>http://www.medworm.com/index.php?rid=4783603&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21165537%26dopt%3DAbstract</link>
            <description>CONCLUSION: Data acquisition of [¹⁸F]FMISO should be done 4 h p.i. to gather the optimal contrast, preferably allowing further analysis, e. g. hypoxic sub volume definition for therapy planning.
    PMID: 21165537 [PubMed - indexed for MEDLINE] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4783603</comments>
            <pubDate>Thu, 05 May 2011 17:30:06 +0100</pubDate>
            <guid isPermaLink="false">4783603</guid>        </item>
        <item>
            <title>Assessment of left ventricular volumes, ejection fraction and mass. Comparison of model-based analysis of ECG-gated (⁹⁹m)Tc-SPECT and ¹⁸F-FDG-PET.</title>
            <link>http://www.medworm.com/index.php?rid=4783602&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21165540%26dopt%3DAbstract</link>
            <description>Authors: Khorsand A, Gyöngyösi M, Sochor H, Maurer G, Karanikas G, Dudczak R, Schuster E, Porenta G, Graf S
    We compared and delineated possible differences of model-based analysis of ECG-gated SPECT using (⁹⁹m)Tc-sestamibi (Tc-SPECT) with ECG-gated ¹⁸F-fluorodeoxyglucose-PET (FDG-PET) for determination of end-diastolic (EDV) and end-systolic (ESV) cardiac volumes, left ventricular ejection fraction (LVEF), and myocardial mass (LVMM).
    PMID: 21165540 [PubMed - indexed for MEDLINE] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4783602</comments>
            <pubDate>Thu, 05 May 2011 17:30:06 +0100</pubDate>
            <guid isPermaLink="false">4783602</guid>        </item>
        <item>
            <title>Third resection of pheochromocytoma aided by preoperative ¹²³I-MIBG scintigraphy and intraoperative gamma probe measurements.</title>
            <link>http://www.medworm.com/index.php?rid=4783601&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21336418%26dopt%3DAbstract</link>
            <description>Authors: Kirkman MA, Forgacs B, Heap S, Howell SJ, Davis JR, McWilliam L, Prescott M, Augustine T
    
    PMID: 21336418 [PubMed - indexed for MEDLINE] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4783601</comments>
            <pubDate>Thu, 05 May 2011 17:30:06 +0100</pubDate>
            <guid isPermaLink="false">4783601</guid>        </item>
        <item>
            <title>[Nuclear Medicine in Germany. Key data from official statistics].</title>
            <link>http://www.medworm.com/index.php?rid=4783600&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21479336%26dopt%3DAbstract</link>
            <description>Authors: Hellwig D, Grgic A, Kotzerke J, Kirsch CM
    To explain the spectrum and number of in-vivo nuclear medicine examinations and therapies based on official statistics about out-patient and in-patient care. Trends in time of the frequency and spectrum of procedures as well as data on the health care structure for nuclear medicine in Germany should be collected.
    PMID: 21479336 [PubMed - in process] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4783600</comments>
            <pubDate>Thu, 05 May 2011 17:30:06 +0100</pubDate>
            <guid isPermaLink="false">4783600</guid>        </item>
        <item>
            <title>[In Process Citation].</title>
            <link>http://www.medworm.com/index.php?rid=4783594&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21542196%26dopt%3DAbstract</link>
            <description>Authors: Burchert W
    
    PMID: 21542196 [PubMed - in process] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4783594</comments>
            <pubDate>Thu, 05 May 2011 17:30:06 +0100</pubDate>
            <guid isPermaLink="false">4783594</guid>        </item>
        <item>
            <title>68Ga-DOTATOC PET/CT of Neuroendocrine Tumors: Spotlight on the CT Phases of a Triple-Phase Protocol.</title>
            <link>http://www.medworm.com/index.php?rid=4783595&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21498531%26dopt%3DAbstract</link>
            <description>Authors: Ruf J, Schiefer J, Furth C, Kosiek O, Kropf S, Heuck F, Denecke T, Pavel M, Pascher A, Wiedenmann B, Amthauer H
    The diagnostic value of neuroendocrine tumor (NET) imaging using PET with integrated CT is dependent on both components. This retrospective study assessed the value of the single CT phases of a triple-phase (early arterial, portal-venous inflow, and venous) CT protocol in comparison to (68)Ga-DOTATOC PET in a masked reading.
    PMID: 21498531 [PubMed - in process] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4783595</comments>
            <pubDate>Sat, 30 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4783595</guid>        </item>
        <item>
            <title>Matched pairs for radionuclide-based imaging and therapy.</title>
            <link>http://www.medworm.com/index.php?rid=4783599&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21484377%26dopt%3DAbstract</link>
            <description>Authors: Bockisch A
    
    PMID: 21484377 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4783599</comments>
            <pubDate>Mon, 11 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4783599</guid>        </item>
        <item>
            <title>[Computer-assisted detection of lung cancer in thoracic X-rays.]</title>
            <link>http://www.medworm.com/index.php?rid=4783598&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21487959%26dopt%3DAbstract</link>
            <description>Authors: Karul M
    
    PMID: 21487959 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4783598</comments>
            <pubDate>Thu, 31 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4783598</guid>        </item>
        <item>
            <title>[Necessary, tedious, unnecessary? : Quality assurance in radiology.]</title>
            <link>http://www.medworm.com/index.php?rid=4783597&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21487961%26dopt%3DAbstract</link>
            <description>Authors: Walz M
    
    PMID: 21487961 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4783597</comments>
            <pubDate>Thu, 31 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4783597</guid>        </item>
        <item>
            <title>Pulmonary FDG uptake without a CT counterpart - a pitfall in interpreting PET/CT images.</title>
            <link>http://www.medworm.com/index.php?rid=4783596&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21498287%26dopt%3DAbstract</link>
            <description>We report the case of a focal pulmonary 18F-FDG uptake without CT correlate in an initial staging examination of a patient with squamous cell carcinoma of the base of the tongue. A follow-up study did not show any suspicious lesion in this area, but pneumonia with 18F-FDG uptake in another region of the lung. 18F-FDG foci without pathological CT are a rare finding and have been associated with emboli. In the literature two main mechanisms underlying focal 18F-FDG uptake in pulmonary embolism are mentioned: an inflammatory reaction of a pre-existing vascular thrombus and an iatrogenic microembolism caused during injection. In our case the 18F-FDG accumulation was assessed as an iatrogenic pulmonary microembolism.
    PMID: 21498287 [PubMed - as supplied by publisher] (Source: Nuklearmedizin...</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4783596</comments>
            <pubDate>Sun, 27 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4783596</guid>        </item>
        <item>
            <title>In vivo imaging neurotransmitter function - The rat 6-hydroxydopamine model and its relevance for human Parkinson's disease.</title>
            <link>http://www.medworm.com/index.php?rid=4621490&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21409317%26dopt%3DAbstract</link>
            <description>This article gives an overview of those small animal imaging studies which have been conducted on neurotransmitter function in the rat 6-hydoxydopamine (6-OHDA) model of Parkinson's disease, and discusses findings with respect to the outcome of clinical studies on Parkinsonian patients.
    PMID: 21409317 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4621490</comments>
            <pubDate>Wed, 16 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4621490</guid>        </item>
        <item>
            <title>Lymphoscintigraphy in breast cancer patients after neoadjuvant chemotherapy. Diagnostic value and the work-up of sentinel node negative patients.</title>
            <link>http://www.medworm.com/index.php?rid=4556250&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21336417%26dopt%3DAbstract</link>
            <description>Conclusion: On the basis of our findings, SLNB can not yet be recommended as a reliable staging method in breast cancer patients undergoing neoadjuvant chemotherapy. Patients with clinically positive axillary lymph nodes have a higher chance of unsuccessful lymphatic mapping by lymphoscintigraphy. Performing SLNB before NCTX in clinically node-negative patients may identify the subset of patients in whom axillary lymph node dissection can be omitted. Post NCTX axillary ultrasonography and 18F-FDG-PET/CT can not be suggested as valid axillary staging methods in case of a failed lymphatic mapping.
    PMID: 21336417 [PubMed - in process] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4556250</comments>
            <pubDate>Tue, 08 Mar 2011 16:00:09 +0100</pubDate>
            <guid isPermaLink="false">4556250</guid>        </item>
        <item>
            <title>Third resection of pheochromocytoma aided by preoperative 123I-MIBG scintigraphy and intraoperative gamma probe measurements.</title>
            <link>http://www.medworm.com/index.php?rid=4556249&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21336418%26dopt%3DAbstract</link>
            <description>Authors: Kirkman MA, Forgacs B, Heap S, Howell SJ, Davis JR, McWilliam L, Prescott M, Augustine T
    
    PMID: 21336418 [PubMed - in process] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4556249</comments>
            <pubDate>Tue, 08 Mar 2011 16:00:09 +0100</pubDate>
            <guid isPermaLink="false">4556249</guid>        </item>
        <item>
            <title>[Prognostic Pulmonary and Thoracic Findings in Patients with Unstable Injuries of the Thoracic Spine.]</title>
            <link>http://www.medworm.com/index.php?rid=4556246&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21370221%26dopt%3DAbstract</link>
            <description>CONCLUSION: Multiply injured patients with instable fractures of the thoracic spine display CT findings indicative of non-survival. Image acquisition and interpretation focusing solely on the spine should be avoided to ensure the detection of prognostic injury patterns to the lungs.
    PMID: 21370221 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4556246</comments>
            <pubDate>Wed, 02 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4556246</guid>        </item>
        <item>
            <title>Vergleich der diagnostischen Genauigkeit der Ganzkörper-MRT und Ganzkörper-CT bei malignem Melanom im Stadium III/IV.</title>
            <link>http://www.medworm.com/index.php?rid=4556248&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21352484%26dopt%3DAbstract</link>
            <description>Authors: Hausmann D, Jochum S, Utikal J, Hoffmann RC, Zechmann C, Neff KW, Goerdt S, Schoenberg SO, Dinter DJ
    
    PMID: 21352484 [PubMed - in process] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4556248</comments>
            <pubDate>Tue, 01 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4556248</guid>        </item>
        <item>
            <title>[Positron emission tomography (PET) and PET/CT for guiding therapy in oncology.]</title>
            <link>http://www.medworm.com/index.php?rid=4556247&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21365523%26dopt%3DAbstract</link>
            <description>Authors: Haug AR, Bartenstein P
    
    PMID: 21365523 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4556247</comments>
            <pubDate>Tue, 01 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4556247</guid>        </item>
        <item>
            <title>Blinded-read of bone scintigraphy: the impact on diagnosis and healing time for stress injuries with emphasis on the foot.</title>
            <link>http://www.medworm.com/index.php?rid=4446180&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21285675%26dopt%3DAbstract</link>
            <description>This study evaluated the use of bone scintigraphy (BS) for the diagnosis of stress fractures in athletes and its validity for the prediction of healing time, with a focus on foot injuries.
    PMID: 21285675 [PubMed - in process] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4446180</comments>
            <pubDate>Tue, 08 Feb 2011 07:30:09 +0100</pubDate>
            <guid isPermaLink="false">4446180</guid>        </item>
        <item>
            <title>High resolution BrainPET combined with simultaneous MRI.</title>
            <link>http://www.medworm.com/index.php?rid=4446179&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21286660%26dopt%3DAbstract</link>
            <description>Discussion, conclusion: Initial experiences with the hybrid MRI/BrainPET indicate a promising basis for further developments of this unique technique allowing simultaneous PET imaging combined with both anatomical and functional MRI.
    PMID: 21286660 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4446179</comments>
            <pubDate>Wed, 02 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4446179</guid>        </item>
        <item>
            <title>Die Fossa poplitea - eine Problemzone bei der Sentinel-Lymphonodektomie.</title>
            <link>http://www.medworm.com/index.php?rid=4446181&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21276195%26dopt%3DAbstract</link>
            <description>Authors: Kretschmer L, Sahlmann CO, Bardzik P, Thoms KM, Bertsch HP, Meller J
    
    PMID: 21276195 [PubMed - in process] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4446181</comments>
            <pubDate>Tue, 01 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4446181</guid>        </item>
        <item>
            <title>Positron emission tomography/computed tomography diagnostics by means of fluorine-18-L-dihydroxyphenylalanine in congenital hyperinsulinism.</title>
            <link>http://www.medworm.com/index.php?rid=4383173&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21186000%26dopt%3DAbstract</link>
            <description>Authors: Mohnike W, Barthlen W, Mohnike K, Blankenstein O
    The unfavorable prognosis of congenital hyperinsulinism (CHI) can be avoided if the patients are treated with high-dose glucose infusions and timely surgical intervention. Circumscribed foci used to be identified by selective percutaneous pancreatic vein catheterization and determination of the insulin level. Fluorine-18-L-dihydroxyphenylalanine-positron emission tomography (PET) was developed as a milder alternative for diagnostic localization of focal disease. The uptake of fluorine-18-L-dihydroxyphenylalanine is considerably increased in foci with high insulin synthesis rates. In Berlin, diagnosis was achieved by high definition PET/computed tomography with multiphase contrast media protocols that provided all necessary data ...</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4383173</comments>
            <pubDate>Sat, 22 Jan 2011 09:00:25 +0100</pubDate>
            <guid isPermaLink="false">4383173</guid>        </item>
        <item>
            <title>Can 18F-FDG PET/CT predict recurrence in patients with cutaneous malignant melanoma?</title>
            <link>http://www.medworm.com/index.php?rid=4383170&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21246162%26dopt%3DAbstract</link>
            <description>Conclusion: Preoperative SUVmax of primary lesion was found to be the most potent predictor of recurrence in CMM patient. Patients with high SUV max of primary lesion should be followed meticulously for recurrence.
    PMID: 21246162 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4383170</comments>
            <pubDate>Wed, 19 Jan 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4383170</guid>        </item>
        <item>
            <title>One should not just read what one believes: the nearly irresolvable issue of producing truly objective, evidence-based guidelines for the management of differentiated thyroid cancer.</title>
            <link>http://www.medworm.com/index.php?rid=4383171&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21243355%26dopt%3DAbstract</link>
            <description>Authors: Dietlein M, Verburg FA, Luster M, Reiners C, Pitoia F, Schicha H
    
    PMID: 21243355 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4383171</comments>
            <pubDate>Tue, 18 Jan 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4383171</guid>        </item>
        <item>
            <title>[Nuclear Medicine Imaging for Diagnosis of CRPS I.]</title>
            <link>http://www.medworm.com/index.php?rid=4383172&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21225569%26dopt%3DAbstract</link>
            <description>Authors: Nitzsche EU
    A three-phase bone scan, before conventional radiography shows morphological changes in CRPS 1, represents a valuable diagnostic tool thanks to the depiction of pathognomonic findings and the localisation ability in all 3 phases. It must be interpreted within the clinical context. In late or subsequent stages the lack of scintigraphic uptake seems to represent the end of the active disease process. The role of three-phase bone scintigraphy in CRPS I is to support or even confirm the diagnosis, given its various presentations. Furthermore, it enables exclusion of other diagnoses such as arthritis, benign or malignant bony lesions, or even metabolic bone diseases such as Paget's disease, particularly if an integrated SPECT/CT is added. Moreover, the earlier the diagn...</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4383172</comments>
            <pubDate>Tue, 11 Jan 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4383172</guid>        </item>
        <item>
            <title>PET surveillance of patients with Ewing sarcomas of the trunk: Must the lower legs be included?</title>
            <link>http://www.medworm.com/index.php?rid=4289761&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20617278%26dopt%3DAbstract</link>
            <description>Authors: Vrachimis A, Dirksen U, Wessling J, Wenning C, Stegger L, Franzius C, Juergens H, Schober O, Weckesser M
    FDG-PET(/CT) is frequently used in surveillance of Ewing sarcoma (ES) patients. Since ES and PNET (primitive neuroectodermal tumours) may cause peripheral metastases some centers routinely recommend whole body PET acquisition from head to toe what may necessitate repositioning of the patient and thus extending examination time. It is not clear yet whether inclusion of lower leg adds to the diagnostic accuracy of PET scanning, especially in primary tumors of the trunk. PATIENTS, METHOD: 40 patients with ES and PNET of the trunk who were referred for surveillance after primary therapy with complete remission, were evaluated retrospectively: 27 men, 13 women; mean age at diagn...</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4289761</comments>
            <pubDate>Mon, 27 Dec 2010 11:40:08 +0100</pubDate>
            <guid isPermaLink="false">4289761</guid>        </item>
        <item>
            <title>[Bone scanning with sodium 18F-fluoride PET and PET/CT. German guideline Version 1.0.].</title>
            <link>http://www.medworm.com/index.php?rid=4289690&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20838734%26dopt%3DAbstract</link>
            <description>Authors: Hellwig D, Krause BJ, Schirrmeister H, Freesmeyer M
    In nuclear medicine, bone scanning is based on the principle of scintigraphy using bone-seeking radiopharmaceuticals which accumulate in sites of increased bone formation. From a historical point of view, (18)F-fluoride was one of the first osteotropic tracers which was replaced by (99m)Tc-labelled polyphosphonates. With the development of modern PET equipment the superior diagnostic performance of (18)F-fluoride PET for the detection and characterization of osseous lesions was proven in comparison to conventional bone scanning. Recently, its importance as a substitute of conventional skeletal scintigraphy increased in a time with limited availability of (99)Mo/(99m)Tc. To ensure health care during this period, (18)F-fluoride...</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4289690</comments>
            <pubDate>Mon, 27 Dec 2010 11:40:08 +0100</pubDate>
            <guid isPermaLink="false">4289690</guid>        </item>
        <item>
            <title>[Care of thyroid carcinoma in pregnancy: Thyroglobulin content].</title>
            <link>http://www.medworm.com/index.php?rid=4289666&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20931151%26dopt%3DAbstract</link>
            <description>Authors: Staudt J, Happel C, Middendorp M, Grünwald F
    
    PMID: 20931151 [PubMed - indexed for MEDLINE] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4289666</comments>
            <pubDate>Mon, 27 Dec 2010 11:40:07 +0100</pubDate>
            <guid isPermaLink="false">4289666</guid>        </item>
        <item>
            <title>Have you ever heard of hibernoma? A rare but important pitfall in FDG-PET/CT.</title>
            <link>http://www.medworm.com/index.php?rid=4263291&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21140031%26dopt%3DAbstract</link>
            <description>Authors: Schmidt F, Cathomas R, Stallmach T, Putora PM, Mueller J
    
    PMID: 21140031 [PubMed - in process] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4263291</comments>
            <pubDate>Sat, 18 Dec 2010 01:30:15 +0100</pubDate>
            <guid isPermaLink="false">4263291</guid>        </item>
        <item>
            <title>Papillary carcinoma simultaneously involving thyroid, neck lymph-nodes, ovary and bone marrow.</title>
            <link>http://www.medworm.com/index.php?rid=4263289&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21140033%26dopt%3DAbstract</link>
            <description>Authors: Giovanella L, Suriano S, Ceriani L, Verburg FA
    
    PMID: 21140033 [PubMed - in process] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4263289</comments>
            <pubDate>Sat, 18 Dec 2010 01:30:15 +0100</pubDate>
            <guid isPermaLink="false">4263289</guid>        </item>
        <item>
            <title>False positive and false negative thyroid 99mTc-sestamibi scintigraphy in the same patient.</title>
            <link>http://www.medworm.com/index.php?rid=4263288&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21140034%26dopt%3DAbstract</link>
            <description>Authors: Gholamrezanezhad A, Muckle M, Ahmadzadehfar H, Biersack HJ, Ezziddin S
    
    PMID: 21140034 [PubMed - in process] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4263288</comments>
            <pubDate>Sat, 18 Dec 2010 01:30:15 +0100</pubDate>
            <guid isPermaLink="false">4263288</guid>        </item>
        <item>
            <title>Intrathoracic metastatic spread of parathyroid carcinoma.</title>
            <link>http://www.medworm.com/index.php?rid=4263287&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21140035%26dopt%3DAbstract</link>
            <description>Authors: Maier-Funk C, Weber T, Lang G, Hügl S, Reske SN, Luster M
    
    PMID: 21140035 [PubMed - in process] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4263287</comments>
            <pubDate>Sat, 18 Dec 2010 01:30:15 +0100</pubDate>
            <guid isPermaLink="false">4263287</guid>        </item>
        <item>
            <title>[Is CT screening for ovarian cancer meaningful? : Study: procedure good, findings less so.]</title>
            <link>http://www.medworm.com/index.php?rid=4263272&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21153800%26dopt%3DAbstract</link>
            <description>Authors: Neumann A
    
    PMID: 21153800 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4263272</comments>
            <pubDate>Wed, 15 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4263272</guid>        </item>
        <item>
            <title>[Metastasen in der Schilddrüse.]</title>
            <link>http://www.medworm.com/index.php?rid=4263292&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21140030%26dopt%3DAbstract</link>
            <description>Authors: Graeser C, Korman E, Zieren HU
    
    PMID: 21140030 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4263292</comments>
            <pubDate>Tue, 07 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4263292</guid>        </item>
        <item>
            <title>[Der Erfolg hat viele Väter.]</title>
            <link>http://www.medworm.com/index.php?rid=4263290&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21140032%26dopt%3DAbstract</link>
            <description>Authors: Kotzerke J
    
    PMID: 21140032 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4263290</comments>
            <pubDate>Tue, 07 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4263290</guid>        </item>
        <item>
            <title>[Radiogenic nephropathy.]</title>
            <link>http://www.medworm.com/index.php?rid=4263286&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21152681%26dopt%3DAbstract</link>
            <description>Conclusion: More complex models have to be used for clinical kidney dosimetry in internal radiotherapy. In this paper, we give a concise overview of the reasons for accumulation of radiotracers in the kidney, the most recent developments in kidney dosimetry, and approaches to reduce the kidney uptake of radiotracers in order to avoid radiogenic nephropathy.
    PMID: 21152681 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4263286</comments>
            <pubDate>Tue, 07 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4263286</guid>        </item>
        <item>
            <title>[Radiation effect in normal tissue - Principles of damage and protection.]</title>
            <link>http://www.medworm.com/index.php?rid=4263285&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21152682%26dopt%3DAbstract</link>
            <description>Authors: Dörr W
    The curative effectivity of external or internal radiotherapy necessitates exposure of normal tissues with significant radiation doses, and hence must be associated with an accepted rate of side effects. These complications can not a priori be considered as an indication of a too aggressive therapy. Based on the time of first diagnosis, early (acute) and late (chronic) radiation sequelae in normal tissues can be distinguished. Early reactions per definition occur within 90 days after onset of the radiation exposure. They are based on impairment of cell production in turnover tissues, which in face of ongoing cell loss results in hypoplasia and eventually a complete loss of functional cells. The latent time is largely independent of dose and is defined by tissue biology...</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4263285</comments>
            <pubDate>Tue, 07 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4263285</guid>        </item>
        <item>
            <title>[Nuclear medicine meets radiation therapy. The radiooncologist's view.]</title>
            <link>http://www.medworm.com/index.php?rid=4263284&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21152683%26dopt%3DAbstract</link>
            <description>Authors: Schütze C, Krause M, Yaromina A, Zips D, Baumann M
    Radiobiological and cell biological knowledge is increasingly used to further improve local tumour control or to reduce normal tissue damage after radiotherapy. Important research areas are evolving which need to be addressed jointly by nuclear medicine and radiation oncology. For this differences of the biological distribution of diagnostic and therapeutic nuclides compared with the more homogenous dose-distribution of external beam radiotherapy have to be taken into consideration. Examples for interdisciplinary biology-based cancer research in radiation oncology and nuclear medicine include bioimaging of radiobiological parameters characterizing radioresistance, bioimage-guided adaptive radiotherapy, and the combination of ...</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4263284</comments>
            <pubDate>Tue, 07 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4263284</guid>        </item>
        <item>
            <title>[Determination of DNA damage in vitro.]</title>
            <link>http://www.medworm.com/index.php?rid=4263283&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21152684%26dopt%3DAbstract</link>
            <description>Authors: Dikomey E
    Ionising irradiation acts primarily via induction of DNA damage, among which double-strand breaks are the most important lesions. These lesions may lead to lethal chromosome aberrations, which are the main reason for cell inactivation. Double-strand breaks can be repaired by several different mechanisms. The regulation of these mechanisms appears be fairly different for normal and tumour cells. Among different cell lines capacity of double-strand break repair varies by only few percents and is known to be determined mostly by genetic factors. Knowledge about double-strand break repair mechanisms and their regulation is important for the optimal application of ionising irradiation in medicine.
    PMID: 21152684 [PubMed - as supplied by publisher] (Source: Nuklearmedi...</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4263283</comments>
            <pubDate>Tue, 07 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4263283</guid>        </item>
        <item>
            <title>[Strahlenbiologie. Wissen verbindet Nuklearmedizin und Radioonkologie.]</title>
            <link>http://www.medworm.com/index.php?rid=4263282&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21152685%26dopt%3DAbstract</link>
            <description>Authors: Kotzerke J, Baumann M
    
    PMID: 21152685 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4263282</comments>
            <pubDate>Tue, 07 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4263282</guid>        </item>
        <item>
            <title>Membrane receptor signaling and control of DNA repair after exposure to ionizing radiation.</title>
            <link>http://www.medworm.com/index.php?rid=4263281&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21152686%26dopt%3DAbstract</link>
            <description>Authors: Toulany M, Rodemann HP
    Accumulated evidence indicates that activation of erbB family of receptors, when mutated or over-expressed, mediates chemo- and radiotherapy resistance. In this context signaling pathways down-stream of epidermal growth factor receptor (EGFR), when abnormally activated, invoke cell survival mechanisms, which leads to resistance against radiation. In several reports it has been demonstrated that molecular targeting of EGFR signaling enhances the cytotoxic effects of radiotherapy. The radiosensitizing effects of EGFR antagonists correlate with a suppression of the ability of tumor cells to repair radiation-induced DNA double strand breaks (DNA-DSBs) through non-homologous end-joining repair pathway (NHEJ). The purpose of this review is to highlight the fun...</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4263281</comments>
            <pubDate>Tue, 07 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4263281</guid>        </item>
        <item>
            <title>[Dosimety of short-ranged radionuclides.]</title>
            <link>http://www.medworm.com/index.php?rid=4263280&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21152687%26dopt%3DAbstract</link>
            <description>Authors: Lassmann M
    More and more targeted radiotherapies (TRT) are carried out with pure beta-emitters such as 90Y. Normally fixed activities are administered without considering the individual biokinetics increasing the risk of under- or overdosing. In addition, it would be helpful to obtain additional data on dose-response relationships for further optimization of TRTs. Therefore, post-therapeutic dosimetry using quantitative imaging becomes more important. For an optimization of TRTs additional aspects such as the changing dose rate and radiobiological considerations need to be taken into account. This paper provides an overview on bremsstrahlung imaging modalities after therapies with pure beta-emitters. In addition, new dosimetric methods are described which consider dose rate an...</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4263280</comments>
            <pubDate>Tue, 07 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4263280</guid>        </item>
        <item>
            <title>[Bio-IGRT. Biological image-guided radiotherapy.]</title>
            <link>http://www.medworm.com/index.php?rid=4263279&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21152688%26dopt%3DAbstract</link>
            <description>Authors: Yaromina A, Zips D
    Image-guided radiotherapy (IGRT) represents a novel method to precisely deliver radiation to tumours while sparing surrounding normal tissues. Integration of biological imaging using PET or MRI appears to be a promising concept to improve radiotherapy (Bio-IGRT). For this it is essential that biological imaging provides radiobiologically relevant information. Preclinical and clinical investigations into validation of PET tracers and MR methods in the context of curative radiotherapy and of concepts for biology-based escalation of radiation dose as well as other therapeutic interventions are an important task for further cancer research.
    PMID: 21152688 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4263279</comments>
            <pubDate>Tue, 07 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4263279</guid>        </item>
        <item>
            <title>[Tracers in oncology. Preclinical and clinical evaluation.]</title>
            <link>http://www.medworm.com/index.php?rid=4263278&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21152689%26dopt%3DAbstract</link>
            <description>Conclusion: The clinical success of multimodal imaging with PET/CT is expected to promote the combination of MRI and PET in the future.
    PMID: 21152689 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4263278</comments>
            <pubDate>Tue, 07 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4263278</guid>        </item>
        <item>
            <title>[Iodidenrichement in malignant tumours after gene transfer.]</title>
            <link>http://www.medworm.com/index.php?rid=4263277&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21152690%26dopt%3DAbstract</link>
            <description>Authors: Haberkorn U, Askoxylakis V, Markert A, Altmann A
    After the cloning of the gene encoding the sodium-iodide symporter several trials were made to develop a radioiodine treatment for multiple tumour entities based on NIS gene transfer. These studies revealed in vitro as well as in vivo a tremendous enhancement of iodide accumulation, which was followed by a rapid efflux. Therapy effects were observed in vitro by clonogenic assays and in vivo by growth inhibition of the treated tumours. However, the interpretation of these results were largely different. Problems of radioiodine therapy after NIS transfer are low efficiency of gene transfer and the short exposure time for the tumours caused by the rapid efflux. Trials to enhance therapeutic efficiency by co-transfer of the gene enc...</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4263277</comments>
            <pubDate>Tue, 07 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4263277</guid>        </item>
        <item>
            <title>[Overcoming of radiation resistances.]</title>
            <link>http://www.medworm.com/index.php?rid=4263276&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21152691%26dopt%3DAbstract</link>
            <description>Authors: Friesen C, Hormann I, Roscher M, Bacher S, Miltner E
    Despite good achievements in prevention and control, cancer is still a leading cause of death worldwide. The development of resistances against conventional treatment modalities is one of the main causes of failure in the treatment of cancer. Radio- and chemotherapies fail frequently due to intrinsic or acquired resistances in apoptotic signalling pathways or alterations in DNA-repair processes. Targeted radiotherapies employing α-particle-emitting radionuclides and Auger-emitting electrons are a promising approach in cancer treatment to break radio- and chemoresistance by overcoming DNA-repair mechanisms and reversing deficient activation of apoptotic pathways in cancer cells.
    PMID: 21152691 [PubMed - as supplied by pu...</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4263276</comments>
            <pubDate>Tue, 07 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4263276</guid>        </item>
        <item>
            <title>[Metabolic micromilieu in tumours.]</title>
            <link>http://www.medworm.com/index.php?rid=4263275&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21152692%26dopt%3DAbstract</link>
            <description>Conclusion: High lactate tumours are characterized by a higher degree of malignancy and therapeutic resistance.
    PMID: 21152692 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4263275</comments>
            <pubDate>Tue, 07 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4263275</guid>        </item>
        <item>
            <title>Quantification of tumour hypoxia. Functional histology and autoradiography.</title>
            <link>http://www.medworm.com/index.php?rid=4263274&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21152693%26dopt%3DAbstract</link>
            <description>Authors: Bussink J
    Tumor cell hypoxia is considered one of the important causes for radiation resistance. The introduction of IMRT(intensity modulated radiotherapy) allows specific boosting of tumor subvolumes that may harbour these radioresistant tumour cells. PET imaging of these subvolumes can be incorporated into treatment planning. However, at this moment microenvironmental changes visualized and quantified by means of PET-imaging need to be validated by high-resolution microscopic techniques. This will allow interpretation of imaging techniques with intermediate resolution (such as PET/CT) in relation to complex cellular signaling in response to anti-cancer treatments.
    PMID: 21152693 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4263274</comments>
            <pubDate>Tue, 07 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4263274</guid>        </item>
        <item>
            <title>[Biological aspects of radiation in nuclear medicine.]</title>
            <link>http://www.medworm.com/index.php?rid=4263273&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21152694%26dopt%3DAbstract</link>
            <description>Authors: Kotzerke J, Oehme L
    Radiotherapy with unsealed radionuclides differs from external radiotherapy with regard to the radiation quality and energy range, the regional dose uniformity and the time course of irradiation regimen. External radiotherapy is planned precisely and can be applied to a target volume independently from blood flow during a course of irradiation fractions. In contrary, administered radiopharmaceuticals distribute according to their pharmacokinetic properties and generate a continuous irradiation corresponding to the effective halflife. The resulting dose rates are approximately 1Gy/min and 1Gy/h, respectively. The biokinetics of radiopharmaceuticals involves cellular accumulation and retention with highly variable affinity to specific organs that can be modul...</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4263273</comments>
            <pubDate>Tue, 07 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4263273</guid>        </item>
        <item>
            <title>Analysing saturable antibody binding based on serum data and pharmacokinetic modelling.</title>
            <link>http://www.medworm.com/index.php?rid=4238285&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21119226%26dopt%3DAbstract</link>
            <description>In this study we developed a method based on serum activity measurements to investigate this effect in radioimmunotherapy with (90)Y-labelled anti-CD66 antibody. Pretherapeutic and therapeutic serum activity data of ten patients with acute leukaemia were fitted to a set of four parsimonious pharmacokinetic models. All models included the key mechanisms of antibody binding, immunoreactivity and degradation; however, they differed with respect to linear or nonlinear binding and global or individual fitting of the model parameters. The empirically most supported model was chosen according to the corrected Akaike information criterion. The nonlinear models were most supported by the data (sum of probabilities ≈100%). Using the presented method, we identified relevant saturable binding for ra...</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4238285</comments>
            <pubDate>Tue, 30 Nov 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4238285</guid>        </item>
        <item>
            <title>Vertebral arteries: A target for FDG-PET imaging in giant cell arteritis? Clinical, ultrasonographic and PET study in 46 patients.</title>
            <link>http://www.medworm.com/index.php?rid=4163097&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21060976%26dopt%3DAbstract</link>
            <description>Conclusion: In patients with severe GCA and a high TVS the extracranial VA are a good target for PET imaging in active GCA with abnormal findings in 33% of patients with a positive PET. VA abnormalities can be an early and isolated finding in active GCA. PET is superior to US for the detection of active VA-GCA. A strong correlation between VA abnormalities and associated clinical abnormalities existed in 2/3 of patients. PET abnormalities of the VA could be detected in some cases after GC treatment has been started even at high doses.
    PMID: 21060976 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4163097</comments>
            <pubDate>Tue, 09 Nov 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4163097</guid>        </item>
        <item>
            <title>Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan in follicular non Hodgkin's lymphoma. Retrospective preliminary web-based multicenter evaluation of 18F-FDG-PET and CT derived predictive factors.</title>
            <link>http://www.medworm.com/index.php?rid=4163099&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21057722%26dopt%3DAbstract</link>
            <description>Conclusion: The use of a web-based multicenter archiving system for clinical and imaging data is technically feasible in a multicenter setting and allows a central analysis. This preliminary analysis suggests that FDG-PET may predict the likelihood of response to RIT.
    PMID: 21057722 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4163099</comments>
            <pubDate>Mon, 08 Nov 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4163099</guid>        </item>
        <item>
            <title>[Ventilation-perfusion-lungscintigraphy using PET and 68Ga-labeled radiopharmaceuticals.]</title>
            <link>http://www.medworm.com/index.php?rid=4163098&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21057723%26dopt%3DAbstract</link>
            <description>Conclusion: Lung scintigraphy with PET is feasible. Galligas is simple to produce (analogously to technegas). 68Ga labeled microspheres are available. The method is applicable to daily routine and rendered clinically relevant informations.
    PMID: 21057723 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4163098</comments>
            <pubDate>Mon, 08 Nov 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4163098</guid>        </item>
        <item>
            <title>FDG uptake in primary squamous cell carcinoma of the head and neck. The relationship between overexpression of glucose transporters and hexokinases, tumour proliferation and apoptosis.</title>
            <link>http://www.medworm.com/index.php?rid=4163101&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21052609%26dopt%3DAbstract</link>
            <description>Conclusion: FDG SUV pvc proved significantly related to GLUT-1 expression by tumour cells and to the absolute number of apoptotic cells. The latter finding warrants further exploration and confirmation by additional studies.
    PMID: 21052609 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4163101</comments>
            <pubDate>Fri, 05 Nov 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4163101</guid>        </item>
        <item>
            <title>Myocardial perfusion imaging using technetium-99m sestamibi in asymptomatic diabetic patients.</title>
            <link>http://www.medworm.com/index.php?rid=4163100&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21052610%26dopt%3DAbstract</link>
            <description>Conclusion: Occult CAD was present on MPI in 1/3 patients with DM without abnormal electrocardiographic findings or evidence of peripheral arterial disease.
    PMID: 21052610 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4163100</comments>
            <pubDate>Fri, 05 Nov 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4163100</guid>        </item>
        <item>
            <title>[Blood oxygenation level dependent (BOLD)--renal imaging: concepts and applications].</title>
            <link>http://www.medworm.com/index.php?rid=4130923&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20807689%26dopt%3DAbstract</link>
            <description>Authors: Nissen JC, Mie MB, Zöllner FG, Haneder S, Schoenberg SO, Michaely HJ
    Many renal diseases as well as several pharmacons cause a change in renal blood flow and/or renal oxygenation. The blood oxygenation level dependent (BOLD) imaging takes advantage of local field inhomogeneities and is based on a T2*-weighted sequence. BOLD is a non-invasive method allowing an estimation of the renal, particularly the medullary oxygenation, and an indirect measurement of blood flow without administration of contrast agents. Thus, effects of different drugs on the kidney and various renal diseases can be controlled and observed. This work will provide an overview of the studies carried out so far and identify ways how BOLD can be used in clinical studies.
    PMID: 20807689 [PubMed - indexed f...</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4130923</comments>
            <pubDate>Thu, 04 Nov 2010 14:30:05 +0100</pubDate>
            <guid isPermaLink="false">4130923</guid>        </item>
        <item>
            <title>Advanced inoperable type B3 thymoma: Monitoring of a novel therapeutic approach with radio-chemotherapy and sorafenib by FDG-PET and CT.</title>
            <link>http://www.medworm.com/index.php?rid=4074541&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20931150%26dopt%3DAbstract</link>
            <description>Authors: Winder T, Schuster A, Becherer A, Gasser K, De Vries A, Gruber-Moesenbacher U, Muendlein A, Drexel H, Lang A
    
    PMID: 20931150 [PubMed - in process] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4074541</comments>
            <pubDate>Sat, 16 Oct 2010 19:40:03 +0100</pubDate>
            <guid isPermaLink="false">4074541</guid>        </item>
        <item>
            <title>[Nachsorge des Schilddrüsenkarzinoms in der Schwangerschaft: hTg-Verlauf.]</title>
            <link>http://www.medworm.com/index.php?rid=4074540&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20931151%26dopt%3DAbstract</link>
            <description>Authors: Staudt J, Happel C, Middendorp M, Grünwald F
    
    PMID: 20931151 [PubMed - in process] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4074540</comments>
            <pubDate>Sat, 16 Oct 2010 19:40:03 +0100</pubDate>
            <guid isPermaLink="false">4074540</guid>        </item>
        <item>
            <title>Myocardial perfusion alterations observed months after radiotherapy are related to the cellular damage.</title>
            <link>http://www.medworm.com/index.php?rid=4074539&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20949225%26dopt%3DAbstract</link>
            <description>Conclusion: Our findings suggest that the reduced rest myocardial perfusion, occuring months after the radiation, indicates a serious myocard tissue damage which is characterized by myocardial degeneration and fibrosis.
    PMID: 20949225 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4074539</comments>
            <pubDate>Wed, 13 Oct 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4074539</guid>        </item>
        <item>
            <title>[Procedure guideline for sentinel lymph node diagnosis]</title>
            <link>http://www.medworm.com/index.php?rid=4023284&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20485862%26dopt%3DAbstract</link>
            <description>Authors: Vogt H, Schmidt M, Bares R, Brenner W, GrÃ¼nwald F, Kopp J, Reiners C, Schober O, SchÃ¼michen C, Schicha H, Sciuk J, Sudbrock F, Wengenmair H
    The authors present a procedure guideline for scintigraphic detection of sentinel lymph nodes in malignant melanoma and other skin tumours, in breast cancer, in head and neck cancer, and in prostate and penile carcinoma. Important goals of sentinel lymph node scintigraphy comprise reduction of the extent of surgery, lower postoperative morbidity and optimization of histopathological examination focussing on relevant lymph nodes. Sentinel lymph node scintigraphy itself does not diagnose tumorous lymph node involvement and is not indicated when lymph node metastases have been definitely diagnosed before sentinel lymph node scintigraphy...</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4023284</comments>
            <pubDate>Sat, 02 Oct 2010 03:20:03 +0100</pubDate>
            <guid isPermaLink="false">4023284</guid>        </item>
        <item>
            <title>[99mTc reduces clonogenic survival after intracellular uptake in NIS-positive cells in vitro more than 131I]</title>
            <link>http://www.medworm.com/index.php?rid=4023283&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20490428%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Intracellular uptake of 131I and 99mTc increases DNA-damage compared to strict extracellular radiotracer distribution which was demonstrated by means of colony forming assay. Increasing radiotoxicity from intracellular 99mTc is explained most likely by increased dose deposition in cellular structures due to Auger- and conversion-electrons of low range and high local energy deposition.
    PMID: 20490428 [PubMed - indexed for MEDLINE] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4023283</comments>
            <pubDate>Sat, 02 Oct 2010 03:20:03 +0100</pubDate>
            <guid isPermaLink="false">4023283</guid>        </item>
        <item>
            <title>IBZM SPECT and FDG PET in the differential diagnosis of Parkinsonian syndromes: comparison with respect to inter-rater agreement.</title>
            <link>http://www.medworm.com/index.php?rid=4023282&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20502846%26dopt%3DAbstract</link>
            <description>CONCLUSION: In neurodegenerative PS, inter-rater agreement of visual analysis is substantial in both IBZM SPECT and FDG PET. Furthermore, (I) visual analysis of IBZM SPECT is reliable if adequate standardized image display is used, (II) visual analysis of FDG SPMs allows unique categorization as either PD or APS in most subjects, and (III) IBZM SPECT and FDG PET are discordant in a significant fraction of cases.
    PMID: 20502846 [PubMed - indexed for MEDLINE] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4023282</comments>
            <pubDate>Sat, 02 Oct 2010 03:20:03 +0100</pubDate>
            <guid isPermaLink="false">4023282</guid>        </item>
        <item>
            <title>Radiobiological restrictions and tolerance doses of repeated single-fraction hdr-irradiation of intersecting small liver volumes for recurrent hepatic metastases.</title>
            <link>http://www.medworm.com/index.php?rid=4023281&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20507615%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Inactivation of liver parenchyma occurs at a BED of approx. 22 - 24 Gy corresponding to a single dose of ~10 Gy (alpha/beta ~ 5 Gy). This tolerance dose is consistent with the large potential to treat oligotopic and/or recurrent liver metastases by CT-guided HDR brachytherapy without radiation-induced liver disease (RILD). Repeated small volume irradiation may be applied safely within the limits of this study.
    PMID: 20507615 [PubMed - indexed for MEDLINE] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4023281</comments>
            <pubDate>Sat, 02 Oct 2010 03:20:03 +0100</pubDate>
            <guid isPermaLink="false">4023281</guid>        </item>
        <item>
            <title>Lesion concordance, image quality and artefacts in PET/CT: results of a multicenter study.</title>
            <link>http://www.medworm.com/index.php?rid=4023280&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20514387%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: As the image quality in both PET and CT was more than satisfying, CT-artefacts almost never led to diagnostic uncertainties and serious misalignment rarely occurred, PET/CT can be considered as suitable for routine use and may replace single PET- and CT-scans. However, additional reading of the non attenuation corrected PET is mandatory to assure best possible diagnostic confidence in PET. Since approximately half of all lesions found in PET/CT were not concordant, at least in a setting with a diagnostic CT the exams need to be reported by both a nuclear medicine physician and a radiologist in consensus.
    PMID: 20514387 [PubMed - indexed for MEDLINE] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4023280</comments>
            <pubDate>Sat, 02 Oct 2010 03:20:03 +0100</pubDate>
            <guid isPermaLink="false">4023280</guid>        </item>
        <item>
            <title>18F-fluoroethylcholine uptake in arterial vessel walls and cardiovascular risk factors: correlation in a PET-CT study.</title>
            <link>http://www.medworm.com/index.php?rid=4023279&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20532464%26dopt%3DAbstract</link>
            <description>CONCLUSION: Contrary to a recent report, we found in our rather large cohort of elderly prostate cancer patients no significant association between FEC uptake in large vessels and atherosclerotic plaque burden, or the presence of cardiovascular risk factors. In line with prior reports on structural changes in vessels, increased calcified atherosclerotic plaque burden was strongly associated with the occurrence of common cardiovascular risk factors.
    PMID: 20532464 [PubMed - indexed for MEDLINE] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4023279</comments>
            <pubDate>Sat, 02 Oct 2010 03:20:03 +0100</pubDate>
            <guid isPermaLink="false">4023279</guid>        </item>
        <item>
            <title>[E-learning in nuclear medicine - a nationwide survey in Germany]</title>
            <link>http://www.medworm.com/index.php?rid=4023278&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20539918%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Today e-learning concepts for nuclear medicine are available at selected university hospitals only. All responders wish to expand on e-learning but many report the lack of administrative support to do so. These data could be regarded as a basis for discussions of inter-university teaching scenarios.
    PMID: 20539918 [PubMed - indexed for MEDLINE] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4023278</comments>
            <pubDate>Sat, 02 Oct 2010 03:20:03 +0100</pubDate>
            <guid isPermaLink="false">4023278</guid>        </item>
        <item>
            <title>[E-learning in medicine with nuclear medicine as an example]</title>
            <link>http://www.medworm.com/index.php?rid=4023276&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20683547%26dopt%3DAbstract</link>
            <description>Authors: Diessl S, Verburg FA, Luster M, Reiners C
    
    PMID: 20683547 [PubMed - indexed for MEDLINE] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4023276</comments>
            <pubDate>Sat, 02 Oct 2010 03:20:03 +0100</pubDate>
            <guid isPermaLink="false">4023276</guid>        </item>
        <item>
            <title>Recombinant human TSH versus hypothyroidism. Cost-minimization-analysis in the follow-up care of differentiated thyroid carcinoma.</title>
            <link>http://www.medworm.com/index.php?rid=4023275&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20877918%26dopt%3DAbstract</link>
            <description>Conclusion: Hypothyroidism after THW causes significant morbidity and safety risks. The clinical and societal benefits associated with rhTSH are roughly gained at equivalent overall cost to that of THW.
    PMID: 20877918 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4023275</comments>
            <pubDate>Mon, 27 Sep 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4023275</guid>        </item>
        <item>
            <title>[Is it really not possible to use electronic personal dosimeters in clinical exposure situations?]</title>
            <link>http://www.medworm.com/index.php?rid=4023277&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20645221%26dopt%3DAbstract</link>
            <description>CONCLUSION: In the range of scattered radiation of diagnostic X-ray equipment, even in pulsed fields, the use of electronic personal dosimeters is reasonable. Considerable measurement errors can only arise in radiation fields that are not realistic under regular conditions and even in connection with most accidents.
    PMID: 20645221 [PubMed - indexed for MEDLINE] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4023277</comments>
            <pubDate>Tue, 31 Aug 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4023277</guid>        </item>
        <item>
            <title>Parathyroid scintigraphy protocols in Finland in 2010. Results of the query and current status.</title>
            <link>http://www.medworm.com/index.php?rid=3908147&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20737112%26dopt%3DAbstract</link>
            <description>Conclusion: 19 hospitals used 18 different study protocols. Thus, significant variability exists in the current practice of PS in Finland. The protocols should be tested with known phantoms to determine any differences in sensitivities for detecting small active structures. Further studies with phantoms are needed to determine the optimal imaging techniques. The results of these phantom studies will provide guidelines for proposing national recommendations for PS.
    PMID: 20737112 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3908147</comments>
            <pubDate>Tue, 24 Aug 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3908147</guid>        </item>
        <item>
            <title>Development of anti-CD30 radioimmunoconstructs (RICs) for treatment of Hodgkin's lymphoma. Studies with cell lines and animal studies.</title>
            <link>http://www.medworm.com/index.php?rid=3877732&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20126826%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: In-vitro tumour cell affinities of all RICs were promising. However, in-vivo biokinetics tested in the mouse model did not meet expectations. This highlights the importance of developing and testing further new anti-CD30 conjugates.
    PMID: 20126826 [PubMed - indexed for MEDLINE] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3877732</comments>
            <pubDate>Thu, 19 Aug 2010 03:15:07 +0100</pubDate>
            <guid isPermaLink="false">3877732</guid>        </item>
        <item>
            <title>Safety margin in irradiation of colorectal liver metastases: assessment of the control dose of micrometastases.</title>
            <link>http://www.medworm.com/index.php?rid=3877731&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20334657%26dopt%3DAbstract</link>
            <description>CONCLUSION: To prevent loss of local tumor control by continuous growth of micrometastases a threshold dose of 15,4 Gy (single fraction) should be delivered at a distance of 21 mm to the gross tumor margin.
    PMID: 20334657 [PubMed - indexed for MEDLINE] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3877731</comments>
            <pubDate>Thu, 19 Aug 2010 03:15:07 +0100</pubDate>
            <guid isPermaLink="false">3877731</guid>        </item>
        <item>
            <title>18F-FDG-PET and MRI in patients with malignancies of the liver and pancreas. Accuracy of retrospective multimodality image registration by using the CT-component of PET/CT.</title>
            <link>http://www.medworm.com/index.php?rid=3877730&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20407733%26dopt%3DAbstract</link>
            <description>CONCLUSION: Retrospective rigid image fusion of FDG-PET and MRI of the upper abdomen using the CT-component of PET/CT for registration is feasible without adaptation in image acquisition protocols and shows sub-centimeter registration errors in most cases.
    PMID: 20407733 [PubMed - indexed for MEDLINE] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3877730</comments>
            <pubDate>Thu, 19 Aug 2010 03:15:07 +0100</pubDate>
            <guid isPermaLink="false">3877730</guid>        </item>
        <item>
            <title>[Analysis of 18F-FDG uptake pattern in PET for diagnosis of aseptic loosening versus prosthesis infection after total knee arthroplasty. A prospective pilot study]</title>
            <link>http://www.medworm.com/index.php?rid=3877729&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20407734%26dopt%3DAbstract</link>
            <description>CONCLUSION: This pilot study shows that FDG-PET is a promising diagnostic tool for patients with painful knee prostheses. There is a good correlation between PET images and the intraoperative and pathology findings. Its clinical value, however, warrants further evaluation in a larger patient population.
    PMID: 20407734 [PubMed - indexed for MEDLINE] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3877729</comments>
            <pubDate>Thu, 19 Aug 2010 03:15:07 +0100</pubDate>
            <guid isPermaLink="false">3877729</guid>        </item>
        <item>
            <title>Splenic sclerosing haemangioma causes false-positive finding at FDG-PET.</title>
            <link>http://www.medworm.com/index.php?rid=3831729&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20683546%26dopt%3DAbstract</link>
            <description>Authors: Al-Ibraheem A, Buck AK, Dechow T, Ringshausen I, Langer R, Engels HP, Wieder HA, Sciuk J, Schwaiger M, Herrmann K
    
    PMID: 20683546 [PubMed - in process] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3831729</comments>
            <pubDate>Sat, 07 Aug 2010 15:24:03 +0100</pubDate>
            <guid isPermaLink="false">3831729</guid>        </item>
        <item>
            <title>[E-Learning in der Medizin am Beispiel der Nuklearmedizin.]</title>
            <link>http://www.medworm.com/index.php?rid=3831728&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20683547%26dopt%3DAbstract</link>
            <description>Authors: DieÃl S, Verburg FA, Luster M, Reiners C
    
    PMID: 20683547 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3831728</comments>
            <pubDate>Mon, 02 Aug 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3831728</guid>        </item>
        <item>
            <title>Combined evaluation of myocardial perfusion and coronary morphology in the identification of subclinical CAD. Radiation exposure of 13N-ammonia PET/CT.</title>
            <link>http://www.medworm.com/index.php?rid=3817523&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20664888%26dopt%3DAbstract</link>
            <description>Conclusion: 13N-ammonia PET/CT and ECG-pulsing CTA affords cardiac hybrid imaging studies in the evaluation of subclinical CAD with a relatively low mean effective radiation exposure of 8.0+/-1.5mSv.
    PMID: 20664888 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3817523</comments>
            <pubDate>Wed, 21 Jul 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3817523</guid>        </item>
        <item>
            <title>[Imaging diagnostics of the prostate.]</title>
            <link>http://www.medworm.com/index.php?rid=3772999&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20628865%26dopt%3DAbstract</link>
            <description>Authors: Dinter DJ, Weidner AM, Wenz F, Pelzer AE, Michel MS, Schoenberg SO
    Prostate cancer is the most common malignancy of men with approximately 32,000 new cases of prostate cancer in Germany and approximately 11,000 men who would die of the disease each year. For early diagnosis of prostate cancer PSA testing is used, whereas at present screening cannot be recommended due to the lack of confirmed medical and economic benefits. Regarding the imaging modalities, ultrasound of the prostate, currently performed in combination with elastography and histoscanning, magnetic resonance imaging of the prostate in combination with endorectal coils and positron emission tomography combined with computed tomography (PET-CT) are the methods of choice. Using these methods benign prostatitis can b...</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3772999</comments>
            <pubDate>Wed, 14 Jul 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3772999</guid>        </item>
        <item>
            <title>The influence of saliva flow stimulation on the absorbed radiation dose to the salivary glands during radioiodine therapy of thyroid cancer using (124)I PET(/CT) imaging.</title>
            <link>http://www.medworm.com/index.php?rid=3754865&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20625723%26dopt%3DAbstract</link>
            <description>CONCLUSION: The (124)I PET(/CT) salivary gland dosimetry indicated that lemon juice stimulation shortly after (131)I administration in radioiodine therapy increases the absorbed doses to the salivary glands.
    PMID: 20625723 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3754865</comments>
            <pubDate>Mon, 12 Jul 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3754865</guid>        </item>
        <item>
            <title>PET surveillance of patients with Ewing sarcomas of the trunk. Must the lower legs be included?</title>
            <link>http://www.medworm.com/index.php?rid=3740972&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20617278%26dopt%3DAbstract</link>
            <description>Conclusion: Scanning of the lower legs may be omitted during follow-up in patients in whom the primary tumor was located in the trunk and in whom no clinical signs pointing to metastases in the lower legs are present. This provides a sufficient diagnostic power and a shorter examination time, thus increasing patient comfort and scanner availability.
    PMID: 20617278 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3740972</comments>
            <pubDate>Thu, 08 Jul 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3740972</guid>        </item>
        <item>
            <title>[Procedure guidelines for whole-body 18F-FDG PET and PET/CT in children with malignant diseases.]</title>
            <link>http://www.medworm.com/index.php?rid=3740971&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20617279%26dopt%3DAbstract</link>
            <description>Authors: Franzius C, Stauss J, Pfluger T, Juergens KU, Kluge R, Amthauer H, Juergens H, Henze G, Stoever B, Hahn K
    The purpose of these guidelines is to offer the nuclear medicine and the appropriate interdisciplinary team a framework for performing and reporting positron emission tomography (PET) and the combination with computed tomography (PET/CT) in children with malignant diseases mainly using the radiopharmaceutical 18F-fluorodeoxy-glucose (FDG). These guidelines are based on the recent guidelines of the Paediatric Committee of the European Association of Nuclear Medicine (EANM) (57) and have been translated and adapted to the current conditions in Germany. The adaptation of CT-parameters using PET/CT in children is covered in a more detailed way than in the EANM guideline taking...</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3740971</comments>
            <pubDate>Thu, 08 Jul 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3740971</guid>        </item>
        <item>
            <title>Swiss Congress of Nuclear Medicine 2010.</title>
            <link>http://www.medworm.com/index.php?rid=3699850&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20572325%26dopt%3DAbstract</link>
            <description>Authors: Giovanella L
    
    PMID: 20572325 [PubMed - in process] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3699850</comments>
            <pubDate>Sat, 26 Jun 2010 12:03:03 +0100</pubDate>
            <guid isPermaLink="false">3699850</guid>        </item>
        <item>
            <title>Are commonly recommended dosages for vitamin D supplementation too low? Vitamin D status and effects of supplementation on serum 25-hydroxyvitamin D levels-an observational study during clinical practice conditions.</title>
            <link>http://www.medworm.com/index.php?rid=3678989&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20556359%26dopt%3DAbstract</link>
            <description>CONCLUSION: Supplementation with higher vitamin D dosages (2,000-3,000 IU/day) is required to achieve a relevant increase of 25(OH)D and normalisation of PTH.
    PMID: 20556359 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3678989</comments>
            <pubDate>Wed, 16 Jun 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3678989</guid>        </item>
        <item>
            <title>[Chromatographic determination of radiochemical purity - replacement of ITLC SG]</title>
            <link>http://www.medworm.com/index.php?rid=3657219&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20029681%26dopt%3DAbstract</link>
            <description>Conclusion: The proposed method is suitable for routinely measuring the radiochemical purity of radiophamaceuticals.
    PMID: 20029681 [PubMed - indexed for MEDLINE] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3657219</comments>
            <pubDate>Mon, 14 Jun 2010 10:00:03 +0100</pubDate>
            <guid isPermaLink="false">3657219</guid>        </item>
        <item>
            <title>[Myocardial perfusion scintigraphy 2008 in Germany - results of the fourth query]</title>
            <link>http://www.medworm.com/index.php?rid=3657218&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20198276%26dopt%3DAbstract</link>
            <description>CONCLUSION: The MPS numbers from 2005 to 2008 in Germany can be regarded as stable. However, there are considerable shifts from HO and UH to PP. The well known potential of MPS considering risk stratification and functional analysis has not been tapped so far. Both gated SPECT and a quantitative perfusion analysis should be performed routinely in every patient.
    PMID: 20198276 [PubMed - indexed for MEDLINE] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3657218</comments>
            <pubDate>Mon, 14 Jun 2010 10:00:03 +0100</pubDate>
            <guid isPermaLink="false">3657218</guid>        </item>
        <item>
            <title>[Positron emission tomography 2008 in Germany - results of the query and current status]</title>
            <link>http://www.medworm.com/index.php?rid=3657217&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20198277%26dopt%3DAbstract</link>
            <description>CONCLUSION: Relative to the high general standard of diagnostic instrumentation in Germany, PET is less established, in particular when compared with other industrialised countries such as USA and Switzerland.
    PMID: 20198277 [PubMed - indexed for MEDLINE] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3657217</comments>
            <pubDate>Mon, 14 Jun 2010 10:00:03 +0100</pubDate>
            <guid isPermaLink="false">3657217</guid>        </item>
        <item>
            <title>[Nuclear medical inpatient treatment in Germany - analysis of structured quality reports 2004-2008]</title>
            <link>http://www.medworm.com/index.php?rid=3657216&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20198278%26dopt%3DAbstract</link>
            <description>Conclusions: In analogy to the observations from Europe after introduction of an iodine prophylaxis the improved iodine supply in Germany has led to a decline of the radioiodine therapy due to hyperthyroidism.
    PMID: 20198278 [PubMed - indexed for MEDLINE] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3657216</comments>
            <pubDate>Mon, 14 Jun 2010 10:00:03 +0100</pubDate>
            <guid isPermaLink="false">3657216</guid>        </item>
        <item>
            <title>[E-learning in nuclear medicine - a nationwide survey in Germany.]</title>
            <link>http://www.medworm.com/index.php?rid=3657214&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20539918%26dopt%3DAbstract</link>
            <description>Conclusions: Today e-learning concepts for nuclear medicine are available at selected university hospitals only. All responders wish to expand on e-learning but many report the lack of administrative support to do so. These data could be regarded as a basis for discussions of inter-university teaching scenarios.
    PMID: 20539918 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3657214</comments>
            <pubDate>Thu, 10 Jun 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3657214</guid>        </item>
        <item>
            <title>18F-fluoroethylcholine uptake in arterial vessel walls and cardiovascular risk factors. Correlation in a PET-CT study.</title>
            <link>http://www.medworm.com/index.php?rid=3657215&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20532464%26dopt%3DAbstract</link>
            <description>Conclusion: Contrary to a recent report, we found in our rather large cohort of elderly prostate cancer patients no significant association between FEC uptake in large vessels and atherosclerotic plaque burden, or the presence of cardiovascular risk factors. In line with prior reports on structural changes in vessels, increased calcified atherosclerotic plaque burden was strongly associated with the occurrence of common cardiovascular risk factors.
    PMID: 20532464 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3657215</comments>
            <pubDate>Mon, 07 Jun 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3657215</guid>        </item>
        <item>
            <title>Lesion concordance, image quality and artefacts in PET/CT. Results of a multicenter study.</title>
            <link>http://www.medworm.com/index.php?rid=3622345&amp;cid=s_33575_37_f&amp;fid=33575&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20514387%26dopt%3DAbstract</link>
            <description>Conclusions: As the image quality in both PET and CT was more than satisfying, CT-artefacts almost never led to diagnostic uncertainties and serious misalignment rarely occurred, PET/CT can be considered as suitable for routine use and may replace single PET- and CT-scans. However, additional reading of the non attenuation corrected PET is mandatory to assure best possible diagnostic confidence in PET. Since approximately half of all lesions found in PET/CT were not concordant, at least in a setting with a diagnostic CT the exams need to be reported by both a nuclear medicine physician and a radiologist in consensus.
    PMID: 20514387 [PubMed - as supplied by publisher] (Source: Nuklearmedizin)</description>
            <author>Nuklearmedizin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3622345</comments>
            <pubDate>Mon, 31 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3622345</guid>        </item>
    </channel>
</rss>

